Clinical Trial Update: A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer [NA]

View source ↗

Summary

A clinical trial update describing a study to assess Alpha DaRT224 for the treatment of men with non-metastatic locally recurrent prostate cancer; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Locally Recurrent Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Alpha DaRT224

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer | NA | Status: RECRUITING